Dublin, Sept. 25, 2020 (GLOBE NEWSWIRE) -- The "Smartphone-Based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathogens. From RT-PCR to serology tests, and the beginning of new CRISPR-based diagnostics powered by artificial intelligence and machine learning algorithms, a high degree of sensitivity and specificity is possible.

This shift is fostering notable market growth driven further by the possibility of alternate care sites that will provide more affordable and accessible point-of-care diagnostic tests. Genomics is expected to drive the innovation spectrum in this space, changing the paradigm of understanding host-pathogen interaction, creating an opportunity for more personalized prevention. CRISPR-based diagnostic tests to detect SARS-CoV-2 have shown a specificity and sensitivity of 100% on clinical patients, and it is only a matter of time before such tests are implemented in a POC setting.

The infectious disease POCT market is a high growth ecosystem generating a compound annual growth rate (CAGR) of 27.3% from 2019 to 2024. Driven by the impact of the COVID-19 pandemic, the market is expected to witness a growth rate of 70.2% in 2020. The Asia-Pacific (APAC) and the Rest of World (ROW) are expected to emerge as the fastest-growing segment during the forecast period, primarily for carrying the greatest disease burden. Influenza, RSV, and CT are some of the key infectious diseases. The United States will lead the respiratory tract infection (RTI) POCT segment when compared to Europe whereas Europe will surpass the United States in the sexually transmitted infection (STI) POCT segment. India is expected to emerge as the fastest-growing market for STI POCTs in APAC. The top 5 participants account for close to 85% of market share.

An increase in government funding is expected to boost infectious disease prevention and management, supported by a spike in STDs among the millennial generation. Although the RTI POCT segment dominates the infectious disease POCT market, increased vigilance is expected in the STI POCT segment. For POCT innovators, a mix-and-match implementation model is recommended, offering a blend of options chosen individually to best address the requirements of healthcare providers, technology innovators, and the general public, thereby supporting the sustainability of infectious disease POCT programs. Multiplexed POCTs made to detect multiple infectious pathogens from a single specimen will sustain long-term market growth.

Key Topics Covered:

1. Executive Dashboard

2. Growth Environment - Market Overview

3. Growth Environment - Market Forecasts

4. Growth Environment - RTI POCT Segment

5. Growth Environment - STI POCT Segment

6. Growth Environment - Regional Analysis

7. Growth Environment - Competitive Playbook

8. Visioning Scenarios

9. Growth Pipeline

10. Vision and Strategy - Growth Opportunities

11. Brand and Demand - Growth Opportunities

12. Growth Opportunities Matrix

13. Growth Strategy and Implementation

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/4f06c8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900